News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Stephen R. D. Johnston, MD, PhD, FRCP

Articles by Stephen R. D. Johnston, MD, PhD, FRCP

Cost-effectiveness of Extended Adjuvant Letrozole Therapy After 5 Years of Adjuvant Tamoxifen Therapy in Postmenopausal Women With Early-stage Breast Cancer

ByThomas E. Delea, MSIA,Jonathan Karnon, MSc, PhD,Robert E. Smith, MD,Stephen R. D. Johnston, MD, PhD, FRCP,Jane Brandman, BPharm, MS,Jennifer C. Y. Sung, PharmD,Paul E. Goss, MD, PhD, FRCPC, FRCP(UK)

July 15th 2006

Latest Updated Articles

Cost-effectiveness of Extended Adjuvant Letrozole Therapy After 5 Years of Adjuvant Tamoxifen Therapy in Postmenopausal Women With Early-stage Breast Cancer
Published: July 15th 2006 | Updated:

Trending on AJMC

FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause

Revumenib Granted FDA Approval for R/R NPM1-Mutated AML

IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?

AMCP Nexus Bringing the Latest on Health Policy, Drug Access, and Value-Based Care

Low Trial Enrollment, Racial Disparities Limit Breast Cancer Treatment Innovation

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.